189 related articles for article (PubMed ID: 35609087)
1. Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study.
Choffat D; Farhoumand PD; Jaccard E; de la Harpe R; Kraege V; Benmachiche M; Gerber C; Leuzinger S; Podmore C; Truong MK; Dumans-Louis C; Marti C; Reny JL; Aujesky D; Rakovic D; Limacher A; Rossel JB; Baumgartner C; Méan M
PLoS One; 2022; 17(5):e0268833. PubMed ID: 35609087
[TBL] [Abstract][Full Text] [Related]
2. Risk Assessment Models for Venous Thromboembolism in Medical Inpatients.
Häfliger E; Kopp B; Darbellay Farhoumand P; Choffat D; Rossel JB; Reny JL; Aujesky D; Méan M; Baumgartner C
JAMA Netw Open; 2024 May; 7(5):e249980. PubMed ID: 38728035
[TBL] [Abstract][Full Text] [Related]
3. Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients.
Blondon M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Bounameaux H; Righini M; Nendaz M
Thromb Haemost; 2018 Jan; 118(1):82-89. PubMed ID: 29304528
[TBL] [Abstract][Full Text] [Related]
4. External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort.
Blondon M; Righini M; Nendaz M; Glauser F; Robert-Ebadi H; Prandoni P; Barbar S
J Thromb Haemost; 2020 Mar; 18(3):676-680. PubMed ID: 31782886
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Observational Cohort of Clinical Outcomes in Medical Inpatients prescribed Pharmacological Thromboprophylaxis Using Different Clinical Risk Assessment Models(COMPT RAMs).
Chamoun N; Matta S; Aderian SS; Salibi R; Salameh P; Tayeh G; Haddad E; Ghanem H
Sci Rep; 2019 Dec; 9(1):18366. PubMed ID: 31797897
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
[TBL] [Abstract][Full Text] [Related]
7. Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort.
Blondon M; Limacher A; Righini M; Aujesky D; Méan M
Res Pract Thromb Haemost; 2021 Jan; 5(1):142-147. PubMed ID: 33537538
[TBL] [Abstract][Full Text] [Related]
8. Investigation of two general venous thromboembolism risk-stratification models in predicting venous thromboembolic events in TB patients.
Sharif-Kashani B; Azimi M; Tabarsi P; Sadr M; Shirzadi S
Int J Mycobacteriol; 2022; 11(1):83-87. PubMed ID: 35295028
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review.
Pandor A; Tonkins M; Goodacre S; Sworn K; Clowes M; Griffin XL; Holland M; Hunt BJ; de Wit K; Horner D
BMJ Open; 2021 Jul; 11(7):e045672. PubMed ID: 34326045
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
Spyropoulos AC; Ageno W; Cohen AT; Gibson CM; Goldhaber SZ; Raskob G
Thromb Haemost; 2020 Jun; 120(6):924-936. PubMed ID: 32492724
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.
Stuck AK; Spirk D; Schaudt J; Kucher N
Thromb Haemost; 2017 Apr; 117(4):801-808. PubMed ID: 28150851
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center.
Fritz MK; Kincaid SE; Sargent CG; Green AH; Davis GA
J Thromb Thrombolysis; 2021 Jan; 51(1):67-73. PubMed ID: 32447745
[TBL] [Abstract][Full Text] [Related]
13. Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort study.
Moumneh T; Riou J; Douillet D; Henni S; Mottier D; Tritschler T; Le Gal G; Roy PM
J Thromb Haemost; 2020 Jun; 18(6):1398-1407. PubMed ID: 32168402
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa.
Wehmeyer A; Coetzee R; McCartney J
S Afr Med J; 2022 Feb; 112(2):13506. PubMed ID: 35139994
[TBL] [Abstract][Full Text] [Related]
15. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
[TBL] [Abstract][Full Text] [Related]
16. Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.
Barkoudah E; Piazza G; Hecht TEH; Grant P; Deitelzweig S; Fang MC; Fanikos J; Kao CK; Barnes GD; Chen T; Ramishvili T; Schnipper JL; Goldstein JN; Ruff CT; Kaatz S; Schwartz A; Connors JM; Goldhaber SZ
Am J Med; 2020 May; 133 Suppl 1():1-27. PubMed ID: 32362349
[TBL] [Abstract][Full Text] [Related]
17. Validation of Risk Assessment Models Predicting Venous Thromboembolism in Inpatients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Multicenter Cohort Study in China.
Zhou C; Yi Q; Ge H; Wei H; Liu H; Zhang J; Luo Y; Pan P; Zhang J; Peng L; Aili A; Liu Y; Wang M; Tang Y; Wang L; Zhong X; Wang Y; Zhou H;
Thromb Haemost; 2022 Jul; 122(7):1177-1185. PubMed ID: 34758489
[TBL] [Abstract][Full Text] [Related]
18. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.
Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ
JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488
[TBL] [Abstract][Full Text] [Related]
19. Updated clinical models for VTE prediction in hospitalized medical patients.
Gerotziafas GT; Papageorgiou L; Salta S; Nikolopoulou K; Elalamy I
Thromb Res; 2018 Apr; 164 Suppl 1():S62-S69. PubMed ID: 29703486
[TBL] [Abstract][Full Text] [Related]
20. The Use of Risk Scores for Thromboprophylaxis in Medically Ill Patients-Rationale and Design of the RICO trial.
Dentali F; Campanini M; Bonaventura A; Fontanella L; Zuretti F; Tavecchia L; Mumoli N; Gnerre P; Ventrella F; Giustozzi M; Valerio A; Fontanella A
TH Open; 2024 Jan; 8(1):e55-e60. PubMed ID: 38222040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
